Polyethylene Glycol 1450
Excipient (pharmacologically inactive substance)
What is Polyethylene Glycol 1450?
Polyethylene glycol, referred to as PEG, is used as an inactive ingredient in the pharmaceutical industry as a solvent, plasticizer, surfactant, ointment and suppository base, and tablet and capsule lubricant. PEG has low toxicity with systemic absorption less than 0.5%. PEGylation occurs when PEGs are attached to various protein medications, allowing for greater solubility for certain drugs. Examples of PEGylated medications include PEG-interferon alpha (Pegintron) and PEG-filgrastim (Neulasta). PEG is also available as a bowel prep for colonoscopy procedures and as a laxative. PEG 400 indicates the average molecular weight of the specific PEG at 400. PEG 3350 is a laxative available over-the-counter by the name of Miralax. In this case, PEG is considered an active ingredient, even though systemic absorption is less than 0.5%.
 Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 08/19/2011
Top Medications Containing Polyethylene Glycol 1450
- Acetaminophen 80 mg (Rugby Laboratories Inc.)
- Carbamazepine Extended-Release 200 mg (Teva Pharmaceuticals USA Inc.)
- Carbamazepine Extended-Release 300 mg (Teva Pharmaceuticals USA Inc.)
- Carbamazepine Extended-Release 100 mg (Teva Pharmaceuticals USA Inc.)
- Lybrel ethinyl estradiol 0.02 mg / levonorgestrel 0.09 mg (Wyeth)